News

TestAVec Researchers Uncover Possible Reasons For Side Effects of HIV-1 Lentiviral Vectors

TestAVec CSO, Professor Michael Themis, also Head of the Gene Therapy research group at Brunel University London, and his team have...

Merry Christmas from TestAVec

From all of us at TestAVec, we wish you a wonderful Christmas and new year. We look forward to working with you in 2022.

The real patient benefit of gene therapy highlighted by skin transplant

In 2015, a 7 year old patient was presented at a hospital in Germany with severe burns. The patient had suffered debilitating blisters...

Promising gene therapy trial for haemophillia

A Phase 1/2 gene therapy trial conducted at the Children's hospital of Philadelphia have shown promising results in the treatment of...

Positive news for DMD gene therapy

Recent clinical trial results for SRP-9001 show high levels of sustained improvements in patients suffering from Duchene muscular...